Please login to the form below

Not currently logged in
Email:
Password:

AMD

This page shows the latest AMD news and features for those working in and with pharma, biotech and healthcare.

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’ s abicipar matches AMD blockbuster Lucentis in phase III. Bayer's Eylea remains the drug to beat, however. ... Allergan has positive phase III results for a wet age-related macular degeneration (AMD) drug that seems to be at least as good as

Latest news

More from news
Approximately 24 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    treatments for age-related macular degeneration (AMD).

  • The good, the bad and the ugly The good, the bad and the ugly

    In the EU, where there’s a high prevalence of AMD, Bayer has enjoyed great success with Eylea - growing revenues by 18% in 2017, ”says Alice Stevens, analyst, cardiovascular and metabolic ... The company plans to launch the highly anticipated

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular degeneration (AMD).

  • Deal Watch November 2015 Deal Watch November 2015

    The acquisition brings an ophthalmology focus with products for Stargardt's macular degeneration, dry AMD, and myopic macular degeneration. ... 380. Ocata Therapeutics. Astellas Pharma| Laurel. Acquisition - company. Regenerative medicine pipeline focus

  • Pharma deals during May 2014 Pharma deals during May 2014

    Coincidentally two weeks earlier, there was another deal for a product for treating AMD. ... Regeneron also has a time limited first right of negotiation to Avalanche's VEGF agent in phase IIa for AMD.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics